NCT04958876View on ClinicalTrials.gov

Study to Evaluate the Safety of SP-104

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 4, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

SP-104

oral capsule once daily

DRUG

Naltrexone immediate release oral capsules

oral capsule once daily

Trial Locations (2)

1010

Auckland Clinical Studies (NZCR), Auckland

8011

Christchurch Clinical Studies Trust (NZCR), Christchurch

All Listed Sponsors
lead

Scilex Pharmaceuticals, Inc.

INDUSTRY

NCT04958876 - Study to Evaluate the Safety of SP-104 | Biotech Hunter | Biotech Hunter